Can You Just Stop Wegovy, or Does It Need to Be Tapered?

What the trial data showed when participants stopped taking semaglutide

The clearest evidence comes from the one-year follow-up to the STEP 1 trial, published in the New England Journal of Medicine. Adults who had lost an average of around 15% of their body weight on semaglutide 2.4 mg were randomised to stop the medicine at 68 weeks. Over the following 52 weeks (with lifestyle support continuing) they regained roughly two-thirds of what they had lost. By the end of the follow-up period, most of the improvements in blood pressure, blood sugar and cholesterol that came with the weight loss had also partially reversed.

That is not a reason to feel discouraged; it is simply how the biology works. Wegovy suppresses appetite signals and slows gastric emptying. Once semaglutide leaves your system (it has a half-life of roughly a week, so it clears over about five weeks) those signals return. This is not a willpower issue. It is the same mechanism that makes the medicine effective in the first place, working in reverse.

Can you just stop semaglutide abruptly, without tapering? Pharmacologically, yes. Unlike some medicines, GLP-1 receptor agonists do not carry a clinical requirement for a gradual dose reduction before stopping. What you can expect instead is a fairly predictable return of hunger within a few weeks, which is worth planning for practically, especially if you have built routines like preparing your weekly injection the night before from the fridge door and will now need to rethink that structure.

Why people stop Wegovy, and whether the reason changes what happens next

The reasons people stop matter, because they affect what comes next. If you are stopping because of side effects (nausea, reflux, gastrointestinal discomfort) those effects typically ease within a couple of weeks of the last dose. If you are stopping because treatment has run its course or because you have reached a stable weight you are confident maintaining, that is a very different conversation from stopping because supply has been interrupted or cost has become a barrier.

If cost is the issue, it is worth reading about how Wegovy is priced across UK private providers before assuming stopping is the only option, sometimes switching provider or adjusting the plan is more practical than restarting from scratch later. If you are weighing up whether Wegovy is right for your situation at all, our overview of what Wegovy is licensed for in the UK gives useful context.

For people stopping because they have reached NICE's six-month checkpoint with less than 5% weight loss, that is exactly the kind of outcome the guidance anticipates. NICE's appraisal of semaglutide (TA875) is explicit that continuing is reviewed if the response has been insufficient at the maintenance dose, stopping in those circumstances is clinically supported.

What to think about before you stop, pause or continue

Stopping Wegovy is your decision, and it is a legitimate one. A few things are worth considering before you make it.

First, how long you have been on treatment matters. People in the early titration phase who have not yet reached the 2.4 mg maintenance dose have not yet seen the full effect of the medicine. Stopping then means stopping before the trial conditions that produced the 15% average weight loss were ever replicated. That does not make early stopping wrong (side effects at the lower doses are a genuine reason to reassess) but it changes the comparison.

Second, if you are thinking about stopping and then restarting later, it is worth knowing that restarting typically means returning to the starting dose and titrating up again. Our page on starting and stopping Wegovy covers this in more detail, and how to stop Wegovy safely explains what to expect from the process step by step.

Third, the question of what replaces the medicine matters. Sustained weight management after stopping GLP-1 treatment is possible, but it tends to require active attention to eating patterns, physical activity and, for some people, ongoing clinical support. That is not a warning, it is practical information that is more useful to have before you stop than after.

If you are considering semaglutide for the first time, or weighing it up against other options, our guide to semaglutide for weight management in the UK is a useful starting point, and the Wegovy overview covers the licensed doses and how treatment is structured.